Works matching DE "ADEFOVIR dipivoxil"
Results: 91
Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 38, n. 2, p. 98, doi. 10.1111/apt.12344
- By:
- Publication type:
- Article
Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2013, v. 37, n. 7, p. 710, doi. 10.1111/apt.12251
- By:
- Publication type:
- Article
Commentary: combination therapy with two nucleos(t)ide analogues in chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2012, v. 35, n. 12, p. 1482, doi. 10.1111/j.1365-2036.2012.05105.x
- By:
- Publication type:
- Article
Single-drug treatments for chronic hepatitis B: summarising current information by network meta-analysis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2011, v. 34, n. 1, p. 105, doi. 10.1111/j.1365-2036.2011.04689.x
- By:
- Publication type:
- Article
Genetic variation in IL28B and treatment outcome in HBeAg-positive and -negative chronic hepatitis B patients treated with Peg interferon alfa-2a and adefovir.
- Published in:
- Scandinavian Journal of Gastroenterology, 2012, v. 47, n. 4, p. 475, doi. 10.3109/00365521.2011.648952
- By:
- Publication type:
- Article
2014-2016年鮮放孚第302 gp免佳P免药房抗乙型 肝炎病毒核香（酸）类似物启用分析.
- Published in:
- Evaluation & Analysis of Drug-Use in Hospitals of China / Zhongguo Yiyuan Yongyao Pingjia yu Fenxi, 2017, v. 17, n. 9, p. 1168, doi. 10.14009/j.issn.1672-2124.2017.09.006
- By:
- Publication type:
- Article
Adefovir dipivoxil induced hypophosphatemic osteomalacia in chronic hepatitis B: a comparative study of Chinese and foreign case series.
- Published in:
- BMC Pharmacology & Toxicology, 2018, v. 19, n. 1, p. N.PAG, doi. 10.1186/s40360-018-0212-7
- By:
- Publication type:
- Article
Effects of entecavir on peripheral blood lymphocyte profiles in chronic hepatitis B patients with suboptimal responses to adefovir.
- Published in:
- Clinical & Experimental Pharmacology & Physiology, 2014, v. 41, n. 7, p. 514, doi. 10.1111/1440-1681.12245
- By:
- Publication type:
- Article
A different inhibitor is required for overcoming entecavir resistance: a comparison of four rescue therapies in a retrospective study.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 10, p. 2259, doi. 10.1111/bcp.13330
- By:
- Publication type:
- Article
Partial Virological Response to Adefovir Add-On Lamivudine Rescue Therapy in Patients with Lamivudine-Resistant Chronic Hepatitis B.
- Published in:
- Digestion, 2013, v. 87, n. 3, p. 196, doi. 10.1159/000348853
- By:
- Publication type:
- Article
Evaluation of the dynamic pattern of viral evolution in patients with virological breakthrough during treatment with nucleoside/nucleotide analogs by ultra-deep pyrosequencing.
- Published in:
- Molecular Medicine Reports, 2016, v. 13, n. 1, p. 651, doi. 10.3892/mmr.2015.4577
- By:
- Publication type:
- Article
A Simple and Specific Stability- Indicating RP-HPLC Method for Routine Assay of Adefovir Dipivoxil in Bulk and Tablet Dosage Form.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2017, v. 16, n. 1, p. 132
- By:
- Publication type:
- Article
ALT flares during nucleotide analogue therapy are associated with HBsAg loss in genotype A HBeAg‐positive chronic hepatitis B.
- Published in:
- Liver International, 2018, v. 38, n. 10, p. 1760, doi. 10.1111/liv.13716
- By:
- Publication type:
- Article
Clonal evolution of multidrug resistant hepatitis B virus during entecavir rescue therapy.
- Published in:
- Liver International, 2015, v. 35, n. 11, p. 2370, doi. 10.1111/liv.12845
- By:
- Publication type:
- Article
Tenofovir disoproxil fumarate has a substantial efficacy against multidrug-resistant strains of hepatitis B virus.
- Published in:
- Liver International, 2015, v. 35, n. 10, p. 2265, doi. 10.1111/liv.12831
- By:
- Publication type:
- Article
Effect of Peg-interferon α-2a combined with Adefovir in HBV postpartum women with normal levels of ALT and high levels of HBV DNA.
- Published in:
- Liver International, 2015, v. 35, n. 6, p. 1692, doi. 10.1111/liv.12753
- By:
- Publication type:
- Article
Safety and immunogenicity of therapeutic DNA vaccine with antiviral drug in chronic HBV patients and its immunogenicity in mice.
- Published in:
- Liver International, 2015, v. 35, n. 3, p. 805, doi. 10.1111/liv.12530
- By:
- Publication type:
- Article
HBV clinical isolates expressing adefovir resistance mutations show similar tenofovir susceptibilities across genotypes B, C and D.
- Published in:
- Liver International, 2014, v. 34, n. 7, p. 1025, doi. 10.1111/liv.12343
- By:
- Publication type:
- Article
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.
- Published in:
- Liver International, 2013, v. 33, n. 4, p. 580, doi. 10.1111/liv.12091
- By:
- Publication type:
- Article
Adding adefovir vs. switching to entecavir for lamivudine-resistant chronic hepatitis B ( ACE study): a 2-year follow-up randomized controlled trial.
- Published in:
- Liver International, 2013, v. 33, n. 2, p. 244, doi. 10.1111/liv.12036
- By:
- Publication type:
- Article
Lamivudine plus adefovir vs. entecavir in HBeAg-positive hepatitis B with sequential treatment failure of lamivudine and adefovir.
- Published in:
- Liver International, 2012, v. 32, n. 7, p. 1179, doi. 10.1111/j.1478-3231.2012.02793.x
- By:
- Publication type:
- Article
Osteomalacia due to Fanconi's syndrome and renal failure caused by long-term low-dose adefovir dipivoxil.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 1, p. 147, doi. 10.1007/s10157-012-0762-8
- By:
- Publication type:
- Article
A case of adefovir-induced membranous nephropathy related to hepatitis B caused by lamivudine-resistant virus after liver transplant due to Byler's disease.
- Published in:
- Clinical & Experimental Nephrology, 2012, v. 16, n. 5, p. 805, doi. 10.1007/s10157-012-0680-9
- By:
- Publication type:
- Article
Effect of nucleoside analogues in the treatment of hepatitis B cirrhosis and its effect on Th17 cells.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2017, v. 21, n. 2, p. 416
- By:
- Publication type:
- Article
Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2016, v. 20, n. 5, p. 866
- By:
- Publication type:
- Article
Two years efficiency of lamivudine and adefovir dipivoxil combined therapy in chronic hepatitis B patients.
- Published in:
- European Review for Medical & Pharmacological Sciences, 2013, v. 17, n. 5, p. 636
- By:
- Publication type:
- Article
Liquid-Assisted Grinding to Prepare a Cocrystal of Adefovir Dipivoxil Thermodynamically Less Stable than Its Neat Phase.
- Published in:
- Crystals (2073-4352), 2015, v. 5, n. 4, p. 583, doi. 10.3390/cryst5040583
- By:
- Publication type:
- Article
Persistence versus Reversion of 3TC Resistance in HIV-1 Determine the Rate of Emergence of NVP Resistance.
- Published in:
- Viruses (1999-4915), 2012, v. 4, n. 8, p. 1212, doi. 10.3390/v4081212
- By:
- Publication type:
- Article
Rhabdomyolysis due to lamivudine re-administration in a patient with HBV-related hepatic failure caused by interruption of lamivudine and adefovir.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Evaluating the efficacy of switching from lamivudine plus adefovir to tenofovir disoproxil fumarate monotherapy in lamivudine-resistant stable hepatitis B patients.
- Published in:
- PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0190581
- By:
- Publication type:
- Article
Adefovir dipivoxil-induced Fanconi syndrome and its predictive factors: A study of 28 cases.
- Published in:
- Oncology Letters, 2017, v. 13, n. 1, p. 307, doi. 10.3892/ol.2016.5393
- By:
- Publication type:
- Article
Kushenin combined with adefovir dipivoxil affects the HBV-DNA load in serum, immune functions and liver functions of patients with chronic hepatitis B.
- Published in:
- Experimental & Therapeutic Medicine, 2017, v. 14, n. 6, p. 5837, doi. 10.3892/etm.2017.5266
- By:
- Publication type:
- Article
Effect of adefovir dipivoxil on T cell immune function in the treatment of chronic hepatitis B and hepatocirrhosis.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 12, n. 4, p. 2511, doi. 10.3892/etm.2016.3623
- By:
- Publication type:
- Article
Lamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 11, n. 6, p. 2293, doi. 10.3892/etm.2016.3230
- By:
- Publication type:
- Article
Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy.
- Published in:
- Experimental & Therapeutic Medicine, 2016, v. 11, n. 1, p. 117, doi. 10.3892/etm.2015.2855
- By:
- Publication type:
- Article
PEG－ IFNα-2a与阿德福韦酯的联用方式对HBeAg阳性 慢性乙型肝炎疗效的影响.
- Published in:
- Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2017, v. 33, n. 12, p. 2311, doi. 10.3969/j.issn.1001-5256.2017.12.011
- By:
- Publication type:
- Article
Clinical effects of lamivudine combined with adefovir dipivoxil and entecavir alone in 48 - week treatment of HBeAg - positive chronic hepatitis B : preliminary comparative study.
- Published in:
- Journal of Clinical Hepatology / Linchuang Gandanbing Zazhi, 2013, v. 29, n. 7, p. 508, doi. 10.3969/j.issn.1001-5256.2013.07.008
- By:
- Publication type:
- Article
Long-term efficacy and emergence of multidrug resistance in patients with lamivudine-refractory chronic hepatitis B treated by combination therapy with adefovir plus lamivudine.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 6, p. 1094, doi. 10.1007/s00535-013-0864-4
- By:
- Publication type:
- Article
Renal dysfunction and hypophosphatemia during long-term lamivudine plus adefovir dipivoxil therapy in patients with chronic hepatitis B.
- Published in:
- Journal of Gastroenterology, 2014, v. 49, n. 3, p. 470, doi. 10.1007/s00535-013-0779-0
- By:
- Publication type:
- Article
Adefovir dipivoxil is less expensive than lamivudine and associated with similar prognosis in patients with hepatitis B virus-related hepatocellular carcinoma after radical resection.
- Published in:
- OncoTargets & Therapy, 2016, v. 9, p. 6897, doi. 10.2147/OTT.S120062
- By:
- Publication type:
- Article
Hypophosphatemic osteomalacia induced by low-dose adefovir therapy: focus on manifestations in the skeletal system and literature review.
- Published in:
- Journal of Bone & Mineral Metabolism, 2013, v. 31, n. 2, p. 240, doi. 10.1007/s00774-012-0384-y
- By:
- Publication type:
- Article
Octadecyloxyethyl Adefovir Exhibits Potent in vitro and in vivo Cytotoxic Activity and Has Synergistic Effects with Ara-C in Acute Myeloid Leukemia.
- Published in:
- Chemotherapy (0009-3157), 2018, v. 63, n. 4, p. 225, doi. 10.1159/000491705
- By:
- Publication type:
- Article
Efficacy of adefovir dipivoxil combined with a corticosteroid in 38 cases of nephrotic syndrome induced by hepatitis B virus-associated glomerulonephritis.
- Published in:
- Renal Failure, 2014, v. 36, n. 9, p. 1404, doi. 10.3109/0886022X.2014.952745
- By:
- Publication type:
- Article
Synthesis, characterization, molecular modeling, and DNA interaction studies of a Cu(II) complex containing drug of chronic hepatitis B: adefovir dipivoxil.
- Published in:
- Journal of Coordination Chemistry, 2015, v. 68, n. 8, p. 1387, doi. 10.1080/00958972.2015.1013945
- By:
- Publication type:
- Article
Cimicifuga foetida L. plus adefovir effectively inhibits the replication of hepatitis B virus in patients with chronic hepatitis B.
- Published in:
- Biomedical Reports, 2016, v. 4, n. 4, p. 493, doi. 10.3892/br.2016.601
- By:
- Publication type:
- Article
Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Elevation in Serum Concentration of Bone-Specific Alkaline Phosphatase without Elevation in Serum Creatinine Concentration Secondary to Adefovir Dipivoxil Therapy in Chronic Hepatitis B Virus Infection.
- Published in:
- Hepatitis Research & Treatment, 2013, p. 1, doi. 10.1155/2013/739247
- By:
- Publication type:
- Article
Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure.
- Published in:
- Virology Journal, 2015, v. 12, n. 1, p. 1, doi. 10.1186/s12985-015-0323-3
- By:
- Publication type:
- Article
Comparative renal toxicity of hepatitis B drugs.
- Published in:
- 2017
- By:
- Publication type:
- Abstract
Adefovir dipivoxil loaded proliposomal powders with improved hepatoprotective activity: formulation, optimization, pharmacokinetic, and biodistribution studies.
- Published in:
- Journal of Liposome Research, 2018, v. 28, n. 4, p. 259, doi. 10.1080/08982104.2017.1363228
- By:
- Publication type:
- Article